61254-32-8 | (4E)-4-[aziridin-1-yl(methylsulfanyl)methylidene]-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one | C14H15 N3 O S |
61254-18-0 | Aptosimol | C20H18 O7 |
61254-28-2 | (4E)-4-[aziridin-1-yl(methylsulfanyl)methylidene]-5-(4-methylphenyl)-2-phenyl-2,4-dihydro-3H-pyrazol-3-one | C20H19 N3 O S |
61254-22-6 | [(7-chloro-4-oxido-5-phenyl-3H-1,4-benzodiazepin-2-yl)(methyl)amino](furan-2-yl)methanol hydrochloride | C21H19Cl2N3O3 |
61254-00-0 | 1,2,3-Triazolo[4,5-f]indazole-4,8(2H,6H)-dione, 6-acetyl-2-phenyl-, 4-(O-acetyloxime) | C17H12N6O4 |
61254-02-2 | 1,2,3-Triazolo[4,5-f]indazole-4,8(2H,6H)-dione, 6-acetyl-2-phenyl-, 8-(O-acetyloxime), (E)- | C17H12N6O4 |
61254-03-3 | 1,2,3-Triazolo[4,5-f]indazole-4,8(2H,6H)-dione, 6-acetyl-2-phenyl-, 8-(O-acetyloxime), (Z)- | C17H12N6O4 |
61254-04-4 | 1,2,3-Triazolo[4,5-f]indazole-4,8(2H,6H)-dione, 2-phenyl-, 8-(O-acetyloxime), (Z)- | C15H10N6O3 |
61254-05-5 | 1,2,3-Triazolo[4,5-f]indazole-4,8(2H,6H)-dione, 2-phenyl-, 8-(O-acetyloxime), (E)- | C15H10N6O3 |
61254-23-7 | 3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-(2-furanylmethoxymethyl)-N-methyl-5-phenyl-, 4-oxide | C22H20ClN3O3 |
61254-39-5 | 2,3,7-Triazaspiro[4.4]nona-3,6-dien-1-one, 4-(4-methylphenyl)-6-(methylthio)-2-phenyl- | C20H19N3OS |
61254-40-8 | 2,3,7-Triazaspiro[4.4]nona-3,6-dien-1-one, 4-(4-methoxyphenyl)-6-(methylthio)-2-phenyl- | C20H19N3O2S |
61254-41-9 | 2,3,7-Triazaspiro[4.4]nona-3,6-dien-1-one, 4-(4-chlorophenyl)-6-(methylthio)-2-phenyl- | C19H16ClN3OS |
61254-42-0 | 2,3,7-Triazaspiro[4.4]nona-3,6-dien-1-one, 4-(4-bromophenyl)-6-(methylthio)-2-phenyl- | C19H16BrN3OS |